CVS to Pay $315 Million to Settle Opioid Prescription Claims

CVS Pharmacy Inc. has agreed to pay $315 million to settle allegations that it unlawfully filled unnecessary opioid prescriptions, resolving a U.S. Justice Department lawsuit. The suit accused the company of dispensing massive quantities of opioids since 2013, contributing to America's addiction crisis.

Under the terms of the settlement, CVS will also implement new safeguards with the Drug Enforcement Administration (DEA) to ensure that prescriptions for opioids and other controlled substances are only filled when medically necessary. This agreement marks the latest effort by the federal government to hold accountable companies accused of fueling the U.S. addiction and overdose crisis.

"Today's settlement is a significant milestone in the Justice Department's efforts to combat the opioid epidemic by cracking down on pharmacies who unlawfully fulfill prescriptions for controlled substances," Associate Attorney General Stanley Woodward said in a statement. 

CVS stated that its pharmacists are "highly trained in the safe and appropriate use of all medications" and that the company has implemented "best-in-class and first-of-their-kind programs to help our pharmacists make the best decisions on behalf of patients." A spokesperson added, "We strongly disagree with the claims made in this case, and our settlement with the DOJ admits no wrongdoing. We’re pleased to move forward and put this litigation behind us."

The Justice Department's lawsuit, filed in federal court in Rhode Island, originated from a whistleblower complaint by a former CVS employee. The complaint alleged that CVS filled prescriptions for excessive amounts of opioids and other drugs, including those from "from pill mills" where doctors prescribed addictive painkillers without a legitimate medical reason. The lawsuit also contended that the company imposed "unsafe performance targets and staffing levels" that pressured pharmacists to fill prescriptions rapidly without verifying their validity. Many of these prescriptions were billed to and reimbursed by Medicaid and other federal healthcare programs.

CVS, the largest pharmacy chain in the nation, reported over $116 billion in Pharmacy & Consumer Wellness revenue for 2023. The company operates more than 9,000 pharmacies and fills over a billion prescriptions annually. The lawsuit noted that CVS was among the top U.S. dispensers of opioids, selling more than 12 billion doses of the drugs between 2015 and 2020.

Over the past decade, drugmakers, wholesalers, and pharmacies have agreed to more than $50 billion in opioid-related settlements with various levels of U.S. government. These settlements are largely intended to fund efforts to combat the addiction crisis. Prescription opioid overdose deaths rose from 3,442 in 1999 to 17,029 in 2017, according to the Centers for Disease Control and Prevention (CDC). While fatalities have seen an overall decline in recent years, falling to 13,026 in 2023, the crisis remains a significant public health concern.

Opioids are prescription painkillers that can produce pain relief and euphoria, leading to a high potential for addiction. They work by interacting with opioid receptors in the brain and spinal cord, blocking pain signals and triggering dopamine release, which creates feelings of pleasure. However, their use can lead to harmful side effects, including nausea, constipation, confusion, and drowsiness. Misuse can slow breathing, potentially causing brain damage, coma, or death due to oxygen deprivation. Commonly prescribed opioids like Vicodin, OxyContin, and Percocet are typically used for short-term pain management following major surgery, severe injuries, or dental procedures.